Fingerprint
Dive into the research topics of 'Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically